Literature DB >> 29285501

Predictors of response and resistance to checkpoint inhibitors in solid tumors.

Sanjana V Rao1, Amy E Moran2, Julie N Graff3,4.   

Abstract

Entities:  

Year:  2017        PMID： 29285501      PMCID： PMC5733326          DOI： 10.21037/atm.2017.09.35

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  23 in total

1.  A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.

Authors:  Ivraym B Barsoum; Chelsea A Smallwood; D Robert Siemens; Charles H Graham
Journal:  Cancer Res       Date:  2013-12-13       Impact factor: 12.701

2.  Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells.

Authors:  L Gorelik; R A Flavell
Journal:  Nat Med       Date:  2001-10       Impact factor: 53.440

3.  Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance.

Authors:  Whijae Roh; Pei-Ling Chen; Alexandre Reuben; Christine N Spencer; Peter A Prieto; John P Miller; Vancheswaran Gopalakrishnan; Feng Wang; Zachary A Cooper; Sangeetha M Reddy; Curtis Gumbs; Latasha Little; Qing Chang; Wei-Shen Chen; Khalida Wani; Mariana Petaccia De Macedo; Eveline Chen; Jacob L Austin-Breneman; Hong Jiang; Jason Roszik; Michael T Tetzlaff; Michael A Davies; Jeffrey E Gershenwald; Hussein Tawbi; Alexander J Lazar; Patrick Hwu; Wen-Jen Hwu; Adi Diab; Isabella C Glitza; Sapna P Patel; Scott E Woodman; Rodabe N Amaria; Victor G Prieto; Jianhua Hu; Padmanee Sharma; James P Allison; Lynda Chin; Jianhua Zhang; Jennifer A Wargo; P Andrew Futreal
Journal:  Sci Transl Med       Date:  2017-03-01       Impact factor: 17.956

4.  Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials.

Authors:  Jedd D Wolchok; Jeffrey S Weber; Omid Hamid; Celeste Lebbé; Michele Maio; Dirk Schadendorf; Veerle de Pril; Kevin Heller; Tai-Tsang Chen; Ramy Ibrahim; Axel Hoos; Steven J O'Day
Journal:  Cancer Immun       Date:  2010-10-20

5.  Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.

Authors:  Tyler J Curiel; George Coukos; Linhua Zou; Xavier Alvarez; Pui Cheng; Peter Mottram; Melina Evdemon-Hogan; Jose R Conejo-Garcia; Lin Zhang; Matthew Burow; Yun Zhu; Shuang Wei; Ilona Kryczek; Ben Daniel; Alan Gordon; Leann Myers; Andrew Lackner; Mary L Disis; Keith L Knutson; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2004-08-22       Impact factor: 53.440

6.  Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses.

Authors:  Paulo C Rodriguez; David G Quiceno; Jovanny Zabaleta; Blair Ortiz; Arnold H Zea; Maria B Piazuelo; Alberto Delgado; Pelayo Correa; Jason Brayer; Eduardo M Sotomayor; Scott Antonia; Juan B Ochoa; Augusto C Ochoa
Journal:  Cancer Res       Date:  2004-08-15       Impact factor: 12.701

7.  Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.

Authors:  S Valpione; C Martinoli; P Fava; S Mocellin; L G Campana; P Quaglino; P F Ferrucci; J Pigozzo; C Astrua; A Testori; V Chiarion-Sileni
Journal:  Eur J Cancer       Date:  2015-07-27       Impact factor: 9.162

8.  Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy.

Authors:  Weiyi Peng; Jie Qing Chen; Chengwen Liu; Shruti Malu; Caitlin Creasy; Michael T Tetzlaff; Chunyu Xu; Jodi A McKenzie; Chunlei Zhang; Xiaoxuan Liang; Leila J Williams; Wanleng Deng; Guo Chen; Rina Mbofung; Alexander J Lazar; Carlos A Torres-Cabala; Zachary A Cooper; Pei-Ling Chen; Trang N Tieu; Stefani Spranger; Xiaoxing Yu; Chantale Bernatchez; Marie-Andree Forget; Cara Haymaker; Rodabe Amaria; Jennifer L McQuade; Isabella C Glitza; Tina Cascone; Haiyan S Li; Lawrence N Kwong; Timothy P Heffernan; Jianhua Hu; Roland L Bassett; Marcus W Bosenberg; Scott E Woodman; Willem W Overwijk; Gregory Lizée; Jason Roszik; Thomas F Gajewski; Jennifer A Wargo; Jeffrey E Gershenwald; Laszlo Radvanyi; Michael A Davies; Patrick Hwu
Journal:  Cancer Discov       Date:  2015-12-08       Impact factor: 39.397

9.  The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction.

Authors:  Nicole E Scharping; Ashley V Menk; Rebecca S Moreci; Ryan D Whetstone; Rebekah E Dadey; Simon C Watkins; Robert L Ferris; Greg M Delgoffe
Journal:  Immunity       Date:  2016-09-20       Impact factor: 31.745

10.  PD-1 blockade induces responses by inhibiting adaptive immune resistance.

Authors:  Paul C Tumeh; Christina L Harview; Jennifer H Yearley; I Peter Shintaku; Emma J M Taylor; Lidia Robert; Bartosz Chmielowski; Marko Spasic; Gina Henry; Voicu Ciobanu; Alisha N West; Manuel Carmona; Christine Kivork; Elizabeth Seja; Grace Cherry; Antonio J Gutierrez; Tristan R Grogan; Christine Mateus; Gorana Tomasic; John A Glaspy; Ryan O Emerson; Harlan Robins; Robert H Pierce; David A Elashoff; Caroline Robert; Antoni Ribas
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962
View more
  5 in total

1.  Checking autoimmune genetic risk to stratify immune checkpoint inhibitor responders.

Authors:  Animesh A Sinha
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-05       Impact factor: 11.205

Review 2.  Cryoablation and Immunotherapy for Breast Cancer: Overview and Rationale for Combined Therapy.

Authors:  Helaina C Regen-Tuero; Robert C Ward; William M Sikov; Peter J Littrup
Journal:  Radiol Imaging Cancer       Date:  2021-02-26

Review 3.  Resistance mechanisms in melanoma to immuneoncologic therapy with checkpoint inhibitors.

Authors:  Sarah E Fenton; Jeffrey A Sosman; Sunandana Chandra
Journal:  Cancer Drug Resist       Date:  2019-09-19

4.  Proteome and phosphoproteome signatures of recurrence for HPV+ head and neck squamous cell carcinoma.

Authors:  Tomonori Kaneko; Peter Y F Zeng; Xuguang Liu; Rober Abdo; John W Barrett; Qi Zhang; Anthony C Nichols; Shawn Shun-Cheng Li
Journal:  Commun Med (Lond)       Date:  2022-07-30

5.  Deep Learning-Based Body Composition Analysis Predicts Outcome in Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Authors:  Anton Faron; Nikola S Opheys; Sebastian Nowak; Alois M Sprinkart; Alexander Isaak; Maike Theis; Narine Mesropyan; Christoph Endler; Judith Sirokay; Claus C Pieper; Daniel Kuetting; Ulrike Attenberger; Jennifer Landsberg; Julian A Luetkens
Journal:  Diagnostics (Basel)       Date:  2021-12-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.